(Q51034889)

27 March 2018

title

Circulating adipocyte fatty acid-binding protein induces insulin resistance in mice in vivo. (English)

1 reference

27 March 2018

0 references

1 reference

1 reference

2

Nora Klöting

1 reference

27 March 2018

11

Mathias Fasshauer

1 reference

27 March 2018

10

Michael Stumvoll

1 reference

27 March 2018

1

Susan Kralisch

1 reference

27 March 2018

8

Ulrike Lossner

1 reference

27 March 2018

5

Annett Hoffmann

1 reference

27 March 2018

Beate Jessnitzer

7

object named as

Beate Jessnitzer

1 reference

27 March 2018

Ines Sommerer

9

object named as

Ines Sommerer

1 reference

27 March 2018

author name string

Thomas Ebert

3

1 reference

27 March 2018

Matthias Kern

4

1 reference

27 March 2018

Kerstin Krause

6

1 reference

27 March 2018

publication date

10 April 2015

1 reference

27 March 2018

published in

Obesity

1 reference

27 March 2018

volume

23

1 reference

27 March 2018

issue

5

1 reference

27 March 2018

page(s)

1007-1013

1 reference

27 March 2018

Adipocytes as regulators of energy balance and glucose homeostasis

cites work

1 reference

Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?

21 January 2018

1 reference

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein

21 January 2018

1 reference

Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes

21 January 2018

1 reference

Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis

21 January 2018

1 reference

Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2

21 January 2018

1 reference

A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease

21 January 2018

1 reference

Low-expression variant of fatty acid-binding protein 4 favors reduced manifestations of atherosclerotic disease and increased plaque stability.

21 January 2018

1 reference

Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.

21 January 2018

1 reference

Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production

21 January 2018

1 reference

Adipocyte fatty acid-binding protein is released from adipocytes by a non-conventional mechanism

21 January 2018

1 reference

Calcium-dependent release of adipocyte fatty acid binding protein from human adipocytes

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

Vaspin inhibits kallikrein 7 by serpin mechanism

21 January 2018

1 reference

Genetic and biochemical evidence for a functional role of BACE1 in the regulation of insulin mRNA expression

21 January 2018

1 reference

Visfatin is a positive regulator of MCP-1 in human adipocytes in vitro and in mice in vivo

21 January 2018

1 reference

Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome

21 January 2018

1 reference

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein

21 January 2018

1 reference

Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-) mice

21 January 2018

1 reference

FABP4 attenuates PPARγ and adipogenesis and is inversely correlated with PPARγ in adipose tissues.

21 January 2018

1 reference

Dual action of adiponectin on insulin secretion in insulin-resistant mice

21 January 2018

1 reference

Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.

21 January 2018

1 reference

Circulating Adipocyte Fatty Acid-Binding Protein Levels and Cardiovascular Morbidity and Mortality in Patients With Coronary Heart Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/OBY.21057

1 reference

27 March 2018

1 reference

27 March 2018